A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.
Stroke is a leading cause of death and disability worldwide. The importance of lowering blood pressure for reducing the risk of stroke is well established. However, not all the benefits of antihypertensive treatments in stroke can be accounted for by reductions in BP and there may be differences between antihypertensive classes as to which provides optimal protection. Dihydropyridine calcium channel blockers, such as amlodipine, and angiotensin receptor blockers, such as valsartan, represent the two antihypertensive drug classes with the strongest supportive data for the prevention of stroke. Therefore, when combination therapy is required, a combination of these two antihypertensive classes represents a logical approach.
Wang
Ji-Guang
JG
Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. jiguangw@gmail.com
D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D011322:Primary Prevention; D012084:Renin-Angiotensin System / Q000187:drug effects; D012307:Risk Factors; D055502:Secondary Prevention; D020521:Stroke / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers
Diabetes Care. 2001 Dec;24(12):2091-6
11723089
Hypertension. 2006 Sep;48(3):374-84
16864749
Lancet. 2005 Sep 10-16;366(9489):907-13
16154017
J Hypertens. 2005 Dec;23(12):2157-72
16269957
J Hypertens. 2003 Apr;21(4):707-16
12658016
Cerebrovasc Dis. 2006;22(2-3):75-82
16790993
Eur Heart J. 2007 Mar;28(6):685-91
16984929
Hypertension. 2008 Feb;51(2):393-8
18172059
J Hypertens. 2008 Mar;26(3):403-11
18300848
Cerebrovasc Dis. 2007;23(2-3):117-20
17124391
Stroke. 2006 Jul;37(7):1933-40
16763185
J Hypertens. 2006 Jun;24(6):1201-8
16685221
Hypertension. 2006 Sep;48(3):359-61
16894055
Lancet. 1997 Sep 13;350(9080):757-64
9297994
Circulation. 2006 Mar 7;113(9):1213-25
16476843
Lancet. 1999 Feb 20;353(9153):611-6
10030325
Int J Clin Pract. 2006 Oct;60(10):1281-6
16942591
J Am Coll Cardiol. 2004 Apr 21;43(8):1343-7
15093864
Curr Drug Targets. 2007 Jul;8(7):786-93
17630931
Stroke. 2004 Feb;35(2):348-50
14757875
J Hypertens Suppl. 2003 Jun;21(5):S9-14
12953850
J Neurol. 2006 Nov;253(11):1478-83
16786208
J Hum Hypertens. 2000 Oct-Nov;14(10-11):749-63
11095165
N Engl J Med. 2008 Sep 18;359(12):1225-37
18753639
J Am Coll Cardiol. 2005 Mar 1;45(5):712-9
15734615
Hypertens Res. 2008 Feb;31(2):271-9
18360047
Curr Hypertens Rep. 2007 Aug;9(4):299-304
17686381
Am J Med. 2003 Jul;115(1):41-6
12867233
Lancet Neurol. 2002 Jul;1(3):149-56
12849483
Cerebrovasc Dis. 2007;23(5-6):368-80
17337887
JAMA. 2004 Nov 10;292(18):2217-25
15536108
Aging Clin Exp Res. 2002 Jun;14(3):216-20
12387531
Drugs. 2007;67(7):955-63
17488141
J Hypertens. 2005 Mar;23(3):641-8
15716708
Clin Ther. 2007 Feb;29(2):279-89
17472820
BMJ. 2002 Mar 23;324(7339):699-702
11909785
Hypertension. 2007 Jul;50(1):181-8
17502490
Stroke. 2003 Oct;34(10):2380-4
12958319
Am J Cardiovasc Drugs. 2007;7(1):25-37
17355164
JAMA. 2002 Sep 25;288(12):1491-8
12243636
J Hypertens. 2007 Jun;25(6):1105-87
17563527
Circulation. 2007 Jan 30;115(4):459-67
17242284
Ann Intern Med. 2006 Jun 20;144(12):884-93
16785477
Hypertension. 2003 Feb;41(2):218-23
12574085
Lancet. 2002 Mar 23;359(9311):995-1003
11937178
Drugs. 2002;62(3):443-62
11827559
Circulation. 2003 Aug 12;108(6):711-6
12885749
JAMA. 2002 Dec 18;288(23):2981-97
12479763
Pharmacotherapy. 2005 Apr;25(4):531-9
15977915
Stroke. 2008 Feb;39(2):343-8
18162623
Lancet. 2004 Jun 19;363(9426):2022-31
15207952
J Hypertens. 2007 Aug;25(8):1543-53
17620946
Lancet. 2005 Sep 10-16;366(9489):895-906
16154016
J Intern Med. 2007 May;261(5):472-9
17444886
Lancet. 2001 Oct 20;358(9290):1305-15
11684211
Stroke. 1997 Dec;28(12):2557-62
9412649
Lancet. 2002 Dec 14;360(9349):1903-13
12493255
JAMA. 2003 May 21;289(19):2560-72
12748199
Stroke. 2000 Oct;31(10):2478-86
11022082
Blood Press. 2005;14(3):177-83
16036498
Hypertension. 2005 Aug;46(2):386-92
16009786
Lancet. 2004 Jun 19;363(9426):2049-51
15207957
Curr Med Res Opin. 2008 Sep;24(9):2597-607
18812017
Arch Intern Med. 2000 Jan 24;160(2):211-20
10647760
Hypertension. 1998 Sep;32(3):410-6
9740604
Eur J Neurol. 2006 Jun;13(6):581-98
16796582
N Engl J Med. 2000 Jan 20;342(3):145-53
10639539
Curr Med Res Opin. 2008 Jan;24(1):121-7
18031596
N Engl J Med. 2008 Apr 10;358(15):1547-59
18378520
J Hypertens. 2008 Jul;26(7):1282-9
18550998
Hypertens Res. 2005 May;28(5):385-407
16156503
Lancet. 2008 Sep 27;372(9644):1174-83
18757085
Stroke. 2004 Apr;35(4):1024
15053002
Am J Hypertens. 2004 Sep;17(9):793-801
15363822
J Hypertens. 2003 Jun;21(6):1055-76
12777939
Lancet. 2007 Apr 28;369(9571):1431-1439
17467513
J Am Soc Hypertens. 2008 Jul-Aug;2(4):294-302
20409909
BMJ. 2004 Feb 7;328(7435):326
14744823
Lancet. 2000 May 6;355(9215):1575-81
10821360
Clin Ther. 2007 Apr;29(4):563-80
17617280
Stroke. 2002 Sep;33(9):2297-303
12215602
J Clin Hypertens (Greenwich). 2007 May;9(5):355-64
17485971
J Hypertens. 2003 May;21(5):875-86
12714861
Am J Hypertens. 2006 Nov;19(11):1144-9
17070425
Exp Neurol. 2008 Apr;210(2):441-8
18177860
Lancet. 2001 Sep 29;358(9287):1033-41
11589932
Stroke. 2004 Jul;35(7):1726-31
15143297
Lancet. 2008 May 3;371(9623):1513-8
18456100
Stroke. 2005 Jun;36(6):1218-26
15879332
Circulation. 2006 Jun 20;113(24):e873-923
16785347
Circulation. 2000 Sep 26;102(13):1503-10
11004140
Stroke. 2003 Jul;34(7):1699-703
12817109
Lancet. 2003 Nov 8;362(9395):1527-35
14615107
N Engl J Med. 2008 Dec 4;359(23):2417-28
19052124